Pulmonary function abnormalities in children with Henoch-Schönlein purpura

Area of Science:

• Pediatrics
• Rheumatology
• Pulmonology

Background:

• Henoch-Schönlein purpura (HSP) is a systemic vasculitis affecting small vessels.
• Pulmonary involvement, including diffuse alveolar hemorrhage, is a rare but serious complication of HSP.
• Early detection of subclinical lung abnormalities in HSP is crucial for understanding disease progression.

Purpose of the Study:

• To evaluate early lung function abnormalities in children with HSP.
• To determine the relationship between lung function and clinical disease activity.
• To assess if subclinical pulmonary findings predict future lung complications.

Main Methods:

• Pulmonary function tests, including transfer factor for carbon monoxide (TL,COss and TL,COsb), were performed on 15 children with HSP at disease onset.
• A control group of 28 age, height, and weight-matched subjects was used for comparison.
• Lung function tests were repeated after a mean of 21 months in 10 HSP patients.

Main Results:

• Children with HSP exhibited significantly lower TL,COss and TL,COsb during the acute phase compared to controls.
• No significant correlation was found between pulmonary function tests and clinical symptoms, signs, or serum IgA levels at onset.
• While overall TL,COsb improved, recurrences of HSP symptoms were associated with slight TL,COsb impairment in two patients.

Conclusions:

• HSP patients demonstrate early subclinical lung impairment during active disease.
• Isolated pulmonary function abnormalities in HSP do not appear to predict the subsequent development of lung disease.
• Further research is needed to fully understand the long-term implications of subclinical pulmonary involvement in HSP.